Awakening from Alzheimers

The human brain operates in rhythms, with gamma frequencies playing a critical role in cognitive functions such as memory, attention, and learning. In neurodegenerative diseases like Alzheimer’s, these gamma oscillations are disrupted, contributing to the accumulation of harmful proteins such as amyloid-beta and tau. Cognito Therapeutics has developed a pioneering approach using non-invasive light and sound stimulation to restore these rhythms and trigger natural mechanisms for clearing these toxic proteins.
In preclinical and early clinical trials, this method has demonstrated remarkable potential. By stimulating gamma oscillations, the therapy has shown the ability to reduce inflammation, enhance synaptic function, and activate microglia—immune cells responsible for clearing debris and maintaining brain health. For families battling cognitive decline, these results offer hope for improving quality of life and potentially slowing disease progression. Cognito’s research focuses on safety, accessibility, and scalability. Unlike pharmaceutical interventions, this approach avoids invasive procedures or systemic side effects, making it an attractive alternative or complementary treatment for Alzheimer’s.
As the company advances its clinical trials, the implications extend far beyond Alzheimer’s. Cognito’s technology could pave the way for treatments for neurological conditions like Parkinson’s, MS, and traumatic brain injury. https://www.youtube.com/watch?v=dZimBEJpnE8
Join the HOPE Study. Help advance a new way of treating Alzheimer’s disease. Be part of the development of a new non-invasive wearable study device that delivers sensory stimulation and has the potential to slow the progression of mild to moderate Alzheimer’s disease, from the comfort of home. https://www.hopestudyforad.com/locate-a-study-site
Click on a topic below. Bookmarks are sorted by date by default, click the "Newest" or "Custom" icon to sort By name (A-Z), etc. I add a tag such as !, 1, etc. to imply an order of importance. This content is provided by https://glycop.com/

159 bookmarks